I think one of the biggest income producers for Starpharma will end up being when the DEP technology is applied to blockbuster off-patent drugs. This will result in new patents for these old drugs, better efficacy, and fewer side-effects. Generic drug companies will not be happy.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
-0.002(2.00%) |
Mkt cap ! $40.98M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $3.09K | 30.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16397 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 24393 | 1 |
View Market Depth
| Last trade - 15.32pm 11/07/2025 (20 minute delay) ? |
| SPL (ASX) Chart |